Endpoint Clinical

Provides interactive response technology for clinical trials

San Francisco, California, United States

About Endpoint Clinical

Endpoint Clinical provides interactive response technology (IRT) systems designed for clinical trials. Their systems assist with various trial processes such as managing drug supplies, randomizing patients, and scheduling visits. These systems are user-friendly and cater to clients in the life sciences sector, including pharmaceutical and biotechnology companies. Endpoint Clinical differentiates itself by focusing on ease of use and integration with other clinical trial management systems, ensuring that clients can streamline their processes and maintain regulatory compliance. The company's goal is to enhance the efficiency and transparency of clinical trials, allowing sponsors to conduct their research more effectively.

San Francisco, CaliforniaHeadquarters
2009Year Founded
$1.7MTotal Funding
DEBTCompany Stage
Enterprise Software, HealthcareIndustries
201-500Employees

Benefits

Remote Work Options

Risks

Emerging IRT providers with cost-effective solutions threaten Endpoint Clinical's market share.
Rapid AI advancements may outpace Endpoint Clinical's current technology offerings.
Decentralized trials could reduce demand for traditional IRT systems, impacting Endpoint's model.

Differentiation

Endpoint Clinical offers user-friendly IRT systems for clinical trial management.
The company specializes in drug supply management, patient randomization, and visit scheduling.
Endpoint Clinical collaborates with THREAD and Berlinger for integrated clinical trial solutions.

Upsides

Increased adoption of DCTs boosts demand for flexible IRT systems like Endpoint Clinical's.
AI integration in clinical trials offers Endpoint opportunities for advanced analytics.
Personalized medicine trends require sophisticated IRT solutions, benefiting Endpoint Clinical.

Funding

Total raised$1.70 M
StageDEBT
DEBT
2/28/2010
$2